Noxafil and cognitive disorder Patient Reports February 12, 2012

Noxafil Side Effects Report #5858443-5
Noxafil side effect was reported by a Physician from GERMANY on Aug 18, 2008. Female patient, 54 years of age, weighting 169.8 lb, was diagnosed with bronchopulmonary aspergillosis and was treated with Noxafil. After drug was administered, patient experienced the following side effects: cardiac arrest , clonic convulsion, cognitive disorder, disturbance in attention, enuresis, long qt syndrome, loss of consciousness, respiratory arrest, ventricular fibrillation. Noxafil dosage: 800 MG QD PO. During the same period patient was treated with VORICONAZOLE, MEROPENEM, TILIDINI, CLONAZEPAM, MIDAZOLAM, GABAPENTIN, METHOTREXATE, PERFALGAN. Patient was hospitalized. Patient died on 08/04/2008.

Noxafil Side Effects Report #5881500-4
Noxafil side effect was reported by a Physician from GERMANY on Sept 02, 2008. Female patient, 54 years of age, weighting 169.8 lb, was diagnosed with bronchopulmonary aspergillosis and was treated with Noxafil. After drug was administered, patient experienced the following side effects: cardiac arrest , clonic convulsion, cognitive disorder, disturbance in attention, long qt syndrome, loss of consciousness, presyncope, respiratory arrest, ventricular fibrillation. Noxafil dosage: 800 MG;QD;PO. During the same period patient was treated with VORICONAZOLE, MEROPENEM, TILIDIN, CLONAZEPAM, MIDAZOLAM, METHOTREXATE, PERFALGAN, TRIMEPRAMIN. Patient was hospitalized. Patient died on 08/04/2008.

Noxafil Side Effects Report #5901026-9
Noxafil side effect was reported by a Consumer or non-health professional from GERMANY on Sept 19, 2008. Female patient, 54 years of age, weighting 169.8 lb, was diagnosed with bronchopulmonary aspergillosis and was treated with Noxafil. After drug was administered, patient experienced the following side effects: cardiac arrest , cognitive disorder, convulsion, disturbance in attention, long qt syndrome, loss of consciousness, presyncope, respiratory arrest, ventricular fibrillation. Noxafil dosage: 800 MG;QD;PO. During the same period patient was treated with VORICONAZOLE, MEROPENEM, TILIDIN, CLONAZEPAM, MIDAZOLAM, METHOTREXATE, PERFALGAN, TRIMEPRAMIN. Patient was hospitalized. Patient died on 08/04/2008.

Noxafil Side Effects Report #5850605-6
Noxafil side effect was reported by a Physician from GERMANY on Aug 12, 2008. Female patient, 54 years of age, weighting 169.8 lb, was diagnosed with antifungal prophylaxis, aspergillosis and was treated with Noxafil. After drug was administered, patient experienced the following side effects: cardiac arrest , clonic convulsion, cognitive disorder, disturbance in attention, enuresis, long qt syndrome, loss of consciousness, respiratory arrest, tongue biting. Noxafil dosage: 800 MG; QD; PO. During the same period patient was treated with VORICONAZOLE, MEROPENEM, PARACETAMOL, TILIDIN, CLONAZEPAM, MIDAZOLAM, GABAPENTIN, METHOTREXATE. Patient was hospitalized. Patient died on 08/04/2008.